We observed concordant trends that ALDH1A1 levels were lower and USP12 levels were increased in PD patients compared to CTR subjects, on average (although not statistically significant; p‐valueALDH1A1 = .09; p‐valueUSP12 = .5) (Figure S9B–E). Here, USP12 is linked to Parkinson disease.